» Articles » PMID: 15856728

The Behavioural Responses to Illness Questionnaire (BRIQ): a New Predictive Measure of Medically Unexplained Symptoms Following Acute Infection

Overview
Journal Psychol Med
Specialty Psychology
Date 2005 Apr 29
PMID 15856728
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to design a self-report measure of behavioural responses during the acute phase of an illness, in order to assess the importance of these behaviours in the development of ongoing medically unexplained syndromes.

Method: An initial pool of items derived from theoretical models and clinical observation, was piloted on a group of 312 university students to assess the factor structure of the scale and the best fit items. The scale was further validated in a second study of 758 patients who were experiencing Campylobacter gastroenteritis. At 3 months post-infection, patients were sent a second questionnaire assessing symptoms of irritable bowel syndrome (IBS).

Results: Principal components analysis of the items in the student sample yielded a four-factor solution, labelled all-or-nothing behaviour, limiting behaviour, emotional support seeking and practical support seeking. The factor structure was confirmed in the Campylobacter sample, and internal reliability was good. All-or-nothing behaviour was associated with IBS at 3 months post-infection. In contrast, limiting behaviour and practical support seeking at the time of infection appeared to be protective.

Conclusion: The results suggest that this is a valid and reliable measure that can predict the development of a medically unexplained syndrome after acute infection. Overdoing things at the time of infection and then needing to rest for prolonged periods (all-or-nothing behaviour), appears to be a particular risk factor for the development of IBS. Targeted interventions at the time of infection may improve coping and prevent symptoms from becoming chronic.

Citing Articles

Preliminary Feasibility of a Novel Mind-Body Program to Prevent Persistent Concussion Symptoms Among Young Adults With Anxiety: Nonrandomized Open Pilot Study.

Becker M, Stratton Levey N, Yeh G, Giacino J, Iverson G, Silverberg N JMIR Form Res. 2024; 8:e64540.

PMID: 39514283 PMC: 11584528. DOI: 10.2196/64540.


A remotely delivered intervention targeting adults with persisting mild-to-moderate post-concussion symptoms (GAIN Lite): a study protocol for a parallel group randomised trial.

Pedersen S, Thastum M, Odgaard L, Naess-Schmidt E, Pedersen C, Nygaard C Trials. 2024; 25(1):720.

PMID: 39456081 PMC: 11515229. DOI: 10.1186/s13063-024-08546-3.


A Cross-Sectional Investigation of Trait Mindfulness, Concussion Symptom Severity, and Quality of Life in Adults with Persisting Symptoms Postconcussion.

Cairncross M, Ledoux A, Greenberg J, Silverberg N J Integr Complement Med. 2024; 30(7):703-707.

PMID: 38563801 PMC: 11304746. DOI: 10.1089/jicm.2023.0516.


"I completely shut down": A mixed methods evaluation of the fear-avoidance model for young adults with a recent concussion and anxiety.

Lovette B, Briskin E, Grunberg V, Vranceanu A, Greenberg J Rehabil Psychol. 2024; 69(3):206-216.

PMID: 38358710 PMC: 11272430. DOI: 10.1037/rep0000549.


Serum calcitonin gene-related peptide in patients with persistent post-concussion symptoms, including headache: a cohort study.

Eggertsen P, Palmfeldt J, Schytz H, Hay D, Olsen R, Nielsen J J Neurol. 2024; 271(5):2458-2472.

PMID: 38231270 PMC: 11055722. DOI: 10.1007/s00415-024-12181-y.